Home / Drug shortages / Carboplatin Injection

Carboplatin Injection — FDA Drug Shortage

To Be Discontinued — Ingenus Pharmaceuticals LLC

The FDA lists a drug shortage record for Carboplatin Injection (injection) from Ingenus Pharmaceuticals LLC with status To Be Discontinued. The shortage was first posted on 02/20/2026.

Shortage Details

Status
To Be Discontinued
Company
Ingenus Pharmaceuticals LLC
Package NDC
50742-447-45
Dosage Form
Injection
Presentation
Carboplatin, Injection, 450 mg/45 mL (NDC 50742-447-45)
Initial Posting
02/20/2026
Revised Date

FDA data resources